Hanson James S.

CIK 00017448872 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001744887

Recent Transactions

34 trades

Sale
Fortrea Holdings Inc.$FTRE
Common Stock
2025-09-09$10.23/sh−1,677→ 19,092 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Common Stock
2025-09-08+5,788→ 20,769 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2025-09-08−5,788→ 47,167 total
Sale
Fortrea Holdings Inc.$FTRE
Common Stock
2025-06-03$4.17/sh−2,191→ 14,981 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Common Stock
2025-06-02+7,706→ 17,172 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2025-06-02−7,706→ 52,955 total
Sale
Fortrea Holdings Inc.$FTRE
Common Stock
2025-03-14$9.70/sh−1,007→ 9,466 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Common Stock
2025-03-13+2,998→ 10,473 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2025-03-13−2,998→ 60,661 total
Award
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2025-03-07+27,668→ 63,659 total
Award
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2025-03-06+11,577→ 35,991 total
Purchase
Fortrea Holdings Inc.$FTRE
Common Stock
2024-06-12$25.30/sh+2,000→ 7,475 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2024-06-03−7,706→ 24,414 total
Tax Payment
Fortrea Holdings Inc.$FTRE
Common Stock
2024-06-03$24.85/sh−2,231→ 5,475 total
Exercise/Conversion
Fortrea Holdings Inc.$FTRE
Common Stock
2024-06-03+7,706→ 7,706 total
Award
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2024-03-13+8,996→ 32,120 total
Award
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2023-06-30+20,702→ 20,702 total
Award
Fortrea Holdings Inc.$FTRE
Restricted Stock Unit
2023-06-30+23,124→ 23,124 total
Other
Fortrea Holdings Inc.$FTRE
Common Stock
2023-06-20+25→ 25 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-05$5.41/sh−729→ 41,087 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-04$5.58/sh−1,639→ 41,816 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-01-03+17,900→ 43,455 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2023-01-03+35,700→ 35,700 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-01-05$10.61/sh−1,445→ 25,555 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2022-01-03+53,000→ 53,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2022-01-03+12,000→ 27,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-01-04+58,000→ 58,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2021-01-04+11,000→ 15,000 total
Purchase
G1 Therapeutics, Inc.
Common Stock
2020-09-04$14.95/sh+1,000→ 4,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2020-02-06+60,000→ 60,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2019-01-02+60,000→ 60,000 total
Purchase
G1 Therapeutics, Inc.
Common Stock
2018-12-26$18.25/sh+1,000→ 3,000 total
Purchase
G1 Therapeutics, Inc.
Common Stock
2018-12-10$32.51/sh+1,000→ 2,000 total
Award
G1 Therapeutics, Inc.
Stock Option (right to buy)
2018-06-25+140,000→ 140,000 total

Companies

Recent Filings

Address

8 MOORE DRIVE

DURHAM, NC, 27709

View on SEC.gov